Sulagna Kar

510 total citations
6 papers, 329 citations indexed

About

Sulagna Kar is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Sulagna Kar has authored 6 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Organic Chemistry. Recurrent topics in Sulagna Kar's work include CRISPR and Genetic Engineering (2 papers), RNA Interference and Gene Delivery (2 papers) and MicroRNA in disease regulation (2 papers). Sulagna Kar is often cited by papers focused on CRISPR and Genetic Engineering (2 papers), RNA Interference and Gene Delivery (2 papers) and MicroRNA in disease regulation (2 papers). Sulagna Kar collaborates with scholars based in India, Finland and Sweden. Sulagna Kar's co-authors include Rahul Bhattacharjee, Niraj Kumar Jha, Lamha Kumar, Kavindra Kumar Kesari, Sumira Malik, Janne Ruokolainen, Sabya Sachi Das, Danish Iqbal, Abhijit Dey and Shreesh Ojha and has published in prestigious journals such as Materials & Design, Biomedicine & Pharmacotherapy and Critical Reviews in Oncology/Hematology.

In The Last Decade

Sulagna Kar

6 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sulagna Kar India 6 174 103 65 37 32 6 329
Pengcheng Li China 12 179 1.0× 109 1.1× 31 0.5× 25 0.7× 60 1.9× 23 351
Ying Jing China 11 157 0.9× 70 0.7× 27 0.4× 58 1.6× 26 0.8× 24 387
Minyan Chen China 11 224 1.3× 69 0.7× 31 0.5× 70 1.9× 68 2.1× 34 431
Neesar Ahmed India 10 197 1.1× 72 0.7× 45 0.7× 36 1.0× 46 1.4× 23 395
Jingdong Zhu China 9 304 1.7× 99 1.0× 34 0.5× 24 0.6× 43 1.3× 15 464
Mahmoud A. F. Khalil Egypt 10 183 1.1× 164 1.6× 30 0.5× 13 0.4× 35 1.1× 31 373
Cheng‐mei Tian China 13 316 1.8× 100 1.0× 36 0.6× 52 1.4× 52 1.6× 24 534

Countries citing papers authored by Sulagna Kar

Since Specialization
Citations

This map shows the geographic impact of Sulagna Kar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sulagna Kar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sulagna Kar more than expected).

Fields of papers citing papers by Sulagna Kar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sulagna Kar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sulagna Kar. The network helps show where Sulagna Kar may publish in the future.

Co-authorship network of co-authors of Sulagna Kar

This figure shows the co-authorship network connecting the top 25 collaborators of Sulagna Kar. A scholar is included among the top collaborators of Sulagna Kar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sulagna Kar. Sulagna Kar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Bhattacharjee, Rahul, Neeraj Prabhakar, Lamha Kumar, et al.. (2023). Crosstalk between long noncoding RNA and microRNA in Cancer. Cellular Oncology. 46(4). 885–908. 48 indexed citations
2.
Bhattacharjee, Rahul, Arvind Negi, Priya Mitra, et al.. (2023). Nanotheranostics to target antibiotic-resistant bacteria: Strategies and applications. OpenNano. 11. 100138–100138. 45 indexed citations
3.
Bhattacharjee, Rahul, Sabya Sachi Das, Sumira Malik, et al.. (2022). Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies. Critical Reviews in Oncology/Hematology. 174. 103675–103675. 109 indexed citations
4.
Bhattacharjee, Rahul, Lamha Kumar, Sulagna Kar, et al.. (2022). Cellular landscaping of cisplatin resistance in cervical cancer. Biomedicine & Pharmacotherapy. 153. 113345–113345. 53 indexed citations
5.
Bhattacharjee, Rahul, Aditya Nandi, Adrija Sinha, et al.. (2022). Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome. Biomedicine & Pharmacotherapy. 151. 113122–113122. 57 indexed citations
6.
Bhattacharjee, Rahul, Aditya Nandi, Adrija Sinha, et al.. (2022). Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives. Materials & Design. 224. 111415–111415. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pengcheng Li Breakdown of academic impact, for papers by Ying Jing Breakdown of academic impact, for papers by Minyan Chen Breakdown of academic impact, for papers by Neesar Ahmed Breakdown of academic impact, for papers by Jingdong Zhu Breakdown of academic impact, for papers by Mahmoud A. F. Khalil Breakdown of academic impact, for papers by Cheng‐mei Tian
Rankless by CCL
2026